Water

Water

SCHEMBL9949277

CC(CC1CCCCO1)c1ccccc1CCBr.CC(CC1CCCCO1)c1ccccc1CCBr.O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 10/20 0.34
MEN1 known ✓ O00255 2/20 0.34
CHRM2 known ✓ P08172 1/20 0.34
CHRM1 known ✓ P11229 1/20 0.34
SLC6A4 known ✓ P31645 1/20 0.34
OPRM1 known ✓ P35372 1/20 0.34
DRD3 known ✓ P35462 1/20 0.34
HPGD P15428 3/20 0.36
CYP3A4 P08684 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 2/20 0.34
DRD1 P21728 1/20 0.34
KCNH2 Q12809 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
PKM P14618 2/20 0.34
PLK1 P53350 1/20 0.33
MGLL Q99685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9950293 1.00 HPGD (0.36) HPGDHTR2ACYP3A4KMT2AALDH1A1
Water SCHEMBL10181063 0.88 HPGD (0.36) HPGDHTR2ACYP3A4KMT2AALDH1A1
Water SCHEMBL9950902 0.88 HPGD (0.36) HPGDHTR2ACYP3A4KMT2AALDH1A1
Water SCHEMBL10179923 0.88 HPGD (0.38) HPGDHTR2ACYP3A4KMT2AALDH1A1
SCHEMBL9949768 0.85 HTR2A (0.36) HPGDHTR2ACYP3A4KMT2AALDH1A1
Water SCHEMBL10179762 0.81 PKM (0.43) HPGDALDH1A1KDM4ECYP1A2PKM
Water SCHEMBL9949680 0.81 PKM (0.43) HPGDALDH1A1KDM4ECYP1A2PKM
SCHEMBL9615012 0.74 HPGD (0.34) HPGDKMT2AALDH1A1KDM4EMEN1
SCHEMBL9122187 0.69 HPGD (0.39) HPGDKMT2AKDM4EMGLL
SCHEMBL891328 0.69 HPGD (0.59) HPGDCYP3A4ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2474535-B1 SYNTHETIC METHOD OF MONTELUKAST SODIUM INTERMEDIATE SHANDONG NEW TIME PHARMACEUTICAL CO LTD (CN) 2014-07-02 EP disclosed
US-8569508-B2 Synthetic method for montelukast sodium intermediate SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. (CN) 2013-10-29 US disclosed
EP-2474535-A1 SYNTHETIC METHOD OF MONTELUKAST SODIUM INTERMEDIATE Shandong New Time Pharmaceutical Co., Ltd. (CN) 2012-07-11 EP disclosed
US-20120165535-A1 SYNTHETIC METHOD FOR MONTELUKAST SODIUM INTERMEDIATE SHANDONG NEW TIME PHARMACEUTICAL CO. LTD. (CN) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165535-A1 SYNTHETIC METHOD FOR MONTELUKAST SODIUM INTERMEDIATE LTC4S, CMA1, PTGIS HTR2A 1762/4885MEN1 3678/4885CHRM2 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.